A New York cardiologist is suing tech giant Apple over its heartbeat-monitoring smartwatch capabilities, claiming the company lifted his patented HR intervention and has been using the technology without his permission.

The FDA has approved Amarin’s Vascepa—icosapent ethyl—to reduce cardiovascular risk beyond cholesterol-lowering therapy in high-risk patients, making it the first drug of its kind to be approved in the U.S.

At least 80 lawyers have been arrested after a violent altercation between attorneys and physicians left three patients dead at the Punjab Institute of Cardiology in Lahore, Pakistan, the New York Times reports.

Boston Heart Diagnostics of Framingham, Mass., agreed on Dec. 9 to pay $26.67 million to resolve False Claims Act allegations suggesting it paid for patient referrals and improperly billed federal programs for lab testing, U.S. Attorney McGregor W. Scott announced.

Life expectancy in the U.S. is lagging far behind that of other developed nations, according to a review published in the Journal of the American Medical Association—a phenomenon driven by an increase in drug overdoses, suicides and organ system diseases like CVD.

The widow of a 48-year-old man was awarded $6.3 million this week after her husband, who’d been cleared of CVD by his cardiologist six weeks before his death, suffered a fatal heart attack while jogging.

A report published in the European Heart Journal Dec. 10 suggests middle-income countries in Europe suffer most heavily from CVD morbidity and mortality.

The parents of a toddler who died two months after undergoing heart surgery at North Carolina Children’s Hospital are suing the Chapel Hill institution for failing to disclose issues within its pediatric heart surgery program.